LMB-2
As of the edition of 20 October 2026, LMB-2 is a drug: of no established status; acts on EEF2 and IL2RA.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Status not established
- Kind
- Unknown
- Registered trials
- 4, 0 stopped early
- Disease areas
- Blood and lymph; Cancer; Immune system; Lungs and airways
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 2 | 4 | 4 | 0 | 0 |
| All trials | 4 |